Company Number: 14314925

Analysis Date: 2025-07-20 11:53 UTC

1. Industry Classification
   OC PHARMA LTD operates under SIC code 47730, categorised as "Dispensing chemist in specialised stores." This sector is a niche segment within the broader retail pharmacy industry, focusing on specialised pharmaceutical dispensing rather than general retail. Key characteristics include regulatory compliance, controlled drug distribution, patient-specific pharmaceutical services, and often a focus on specialised medicines or therapies. The sector typically involves small to medium-sized enterprises operating within local or regional markets, with strong emphasis on accuracy, customer service, and adherence to healthcare standards.

2. Relative Performance
   As a micro-entity, OC PHARMA LTD’s latest financials show total net assets of £2,249 and net current assets of £2,053 with a single employee. Compared to typical dispensing chemist benchmarks, these figures indicate a very small operation with limited capital investment and working capital. Established in 2022, the company is in early growth or start-up phase. The decline in current assets and net assets from £6,862 in 2023 to £2,249 in 2024 suggests a contraction in liquidity or possibly increased operational expenses without corresponding revenue growth. Industry averages for small pharmacies tend to show higher turnover and asset bases, reflecting inventory stock and receivables. OC PHARMA’s micro classification aligns with minimal fixed asset investment, common for specialist chemists relying on third-party supply chains rather than owning significant property or equipment.

3. Sector Trends Impact
   The UK dispensing chemist sector is influenced by several key trends: increasing demand for specialised medicines (e.g., biologics), growing regulatory scrutiny, digital transformation with online prescription services, and NHS contract reforms impacting remuneration. Additionally, supply chain pressures and inflationary cost rises have affected smaller pharmacies disproportionately. OC PHARMA LTD’s small scale and micro-entity status may restrict its ability to absorb such pressures or invest in technological upgrades. Conversely, the sector’s shift towards personalised medicine and niche therapies could present growth opportunities if the company leverages its specialised focus effectively.

4. Competitive Positioning
   OC PHARMA LTD appears to be a niche player within the specialised dispensing chemist segment. Its micro size and single-employee structure imply limited operational capacity and market reach compared to larger retail pharmacy chains or medium-sized independents that benefit from economies of scale and broader service offerings. Strengths might include agility, a focused business model, and potential for personalised service. However, limited financial resources and a shrinking asset base relative to the prior year suggest vulnerabilities in competitive resilience. Without clear evidence of revenue growth or investment, the company risks being outcompeted by better-capitalised peers or larger groups consolidating market share in specialised dispensing.